Arkolith/Insider Trading/ZIVO/Form 4

Payne John Bernard

President and CEO, DirectorZivo Bioscience, Inc. (ZIVO) · full profile →Form 4 · filed Dec 20, 2022
Net Buying
Open-Market Buys
$143
Open-Market Sells
$0
Net Open-Market Flow
$143
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 19, 2022Buy(P)57$2.50$1439K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001654954-22-016740) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML